A 32-year-old woman developed herpes zoster after injections of semaglutide, botulinum toxin and hyaluronic acid.
In plain wordsOne 32-year-old woman developed shingles after getting injections of semaglutide, botulinum toxin and hyaluronic acid.
- Peptide
- Semaglutide
- Outcome
- Not applicableHerpes zoster after cosmetic injections
- Study
n = 1
- Outcome group
- Adverse events · Infection
Source sentences
This case report describes a 32-year-old female patient who developed herpes zoster after receiving injections of semaglutide, botulinum toxin, and hyaluronic acid.
In this study, Semaglutide was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Semaglutide.